Abstract:The risk of type 2 diabetes (T2D), heart disease, and stroke is elevated by a spectrum of illnesses known as metabolic syndrome (METS). [ 1 ] METS is a cluster of conditions that include abdominal obesity, high blood pressure (BP), high blood sugar levels, and abnormal cholesterol levels. With these conditions, persons are predisposed toward developing T2D and hypertension. [ 2 ] METS increases the risk of developing diabetes and hypertension by promoting insulin resistance, abdominal obesity, dyslipidemia, inflammation, and endothelial dysfunction. [ 3 ] They are often hereditary. [ 4 ] Typically, symptoms appear when the body's metabolism is under stress, such as following a protracted fast or a feverish illness. Families with a prior history of metabolic illnesses or those belonging to a specific ethnic group are usually offered prenatal diagnostic screening. [ 5 ] Age, ethnicity, obesity, and diabetes were found to be the most important causes of METS in previous studies. [ 6 ] Up to one-third of adults in the United States are estimated to have METS, which is becoming more and more prevalent and has few overt symptoms (apart from a big waist circumference). [ 7 , 8 ] The problem is becoming increasingly common in India as well due to changes in lifestyle, diet as well as genetic factors. According to a systematic review and meta-analysis published in 2020, the overall prevalence of METS in India was estimated to be around 24.9%. [ 9 ] Another study published in 2020 found that METS was more common in women than men (39.1% vs. 28.6%). The worldwide occurrence is on the increase, with the global incidence expected to be 20%–25% of the adult population. [ 10 ]

The connection between hypertension and diabetes and their role in heart and kidney disease development